YD Bio (YDESW) Receivables - Other (2024 - 2026)

YD Bio (YDESW) has reported Receivables - Other for 3 consecutive years, with $33636.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other fell 48.76% year-over-year to $33636.0 in Q2 2026; TTM through Jun 2026 was $33636.0, a 48.76% decrease from a year earlier, with the FY2025 full-year figure at $291540.0, up 1622.34% from the prior year.
• Receivables - Other was $33636.0 for Q2 2026 at YD Bio, down from $291540.0 in the prior quarter.
• Over five years, Receivables - Other peaked at $291540.0 in Q4 2025 and troughed at $16927.0 in Q4 2024.
• A 3-year average of $101935.8 and a median of $49638.0 in 2025 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other jumped 1622.34% in 2025 and slumped 48.76% in 2026, its largest moves.
• Over 3 years, Receivables - Other stood at $16927.0 in 2024, then jumped by 1622.34% to $291540.0 in 2025, then plunged by 88.46% to $33636.0 in 2026.
• The last three Receivables - Other figures came in at $33636.0 (Q2 2026), $291540.0 (Q4 2025), and $65640.0 (Q2 2025), per Business Quant data.